Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

GTPase NRas anticorps (N-Term)

NRAS Reactivité: Humain WB, FACS, IF Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN544419
  • Antigène Voir toutes GTPase NRas (NRAS) Anticorps
    GTPase NRas (NRAS)
    Épitope
    • 6
    • 4
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    N-Term
    Reactivité
    • 42
    • 13
    • 5
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 35
    • 10
    • 1
    Lapin
    Clonalité
    • 35
    • 11
    Polyclonal
    Conjugué
    • 32
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp GTPase NRas est non-conjugé
    Application
    • 35
    • 16
    • 8
    • 7
    • 6
    • 6
    • 4
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Flow Cytometry (FACS), Immunofluorescence (IF)
    Fonction
    Rabbit polyclonal antibody raised against synthetic peptide of NRAS.
     Réactivité croisée
    Humain
    Immunogène
    A synthetic peptide (conjugated with KLH) corresponding to N-terminus of human NRAS.
    Top Product
    Discover our top product NRAS Anticorps primaire
  • Indications d'application
    Flow Cytometry (1:10-50)
    Immunofluorescence (1:10-50)
    Western Blot (1:1000)
    The optimal working dilution should be determined by the end user.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    In PBS (0.09 % sodium azide)
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Store at 4°C. For long term storage store at -20°C.
    Aliquot to avoid repeated freezing and thawing.
  • Banerji, Affolter, Judson, Marais, Workman: "BRAF and NRAS mutations in melanoma: potential relationships to clinical response to HSP90 inhibitors." dans: Molecular cancer therapeutics, Vol. 7, Issue 4, pp. 737-9, (2008) (PubMed).

    Smalley, Contractor, Nguyen, Xiao, Edwards, Muthusamy, King, Flaherty, Bosenberg, Herlyn, Nathanson: "Identification of a novel subgroup of melanomas with KIT/cyclin-dependent kinase-4 overexpression." dans: Cancer research, Vol. 68, Issue 14, pp. 5743-52, (2008) (PubMed).

  • Antigène
    GTPase NRas (NRAS)
    Autre désignation
    NRAS (NRAS Produits)
    Synonymes
    anticorps NRAS, anticorps AV095280, anticorps N-ras, anticorps ALPS4, anticorps NRAS1, anticorps NS6, anticorps N-RAS, anticorps fj99a10, anticorps wu:fj99a10, anticorps zgc:100761, anticorps zras-b1, anticorps H-RAS, anticorps HRAS, anticorps GTPase NRas, anticorps neuroblastoma RAS viral (v-ras) oncogene homolog L homeolog, anticorps NRAS proto-oncogene, GTPase, anticorps neuroblastoma ras oncogene, anticorps neuroblastoma RAS viral oncogene homolog, anticorps Tsp_01117, anticorps nras.L, anticorps Nras, anticorps NRAS, anticorps nras
    ID gène
    4893
    Pathways
    Signalisation p53, Signalisation MAPK, Signalisation RTK, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Hepatitis C, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Vous êtes ici:
Support technique